Immunosenescence in neurocritical care

被引:4
|
作者
Inoue, Shigeaki [1 ]
Saito, Masafumi [1 ]
Kotani, Joji [1 ]
机构
[1] Kobe Univ, Dept Disaster & Emergency Med, Grad Sch Med, Kusunoki Cho 7-5-2,Chuo Ward, Kobe, Hyogo 6500017, Japan
来源
关键词
Sepsis; Elderly; Immunosenescence; Immune paralysis; REGULATORY T-CELLS; BLOOD-BRAIN-BARRIER; ISCHEMIC-STROKE; ANTIBODY-RESPONSE; IMPACT; EXPRESSION; SEPSIS; IMMUNODEPRESSION; ENCEPHALOPATHY; ACTIVATION;
D O I
10.1186/s40560-018-0333-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BackgroundSeveral advanced and developing countries are now entering a superaged society, in which the percentage of elderly people exceeds 20% of the total population. In such an aging society, the number of age-related diseases such as malignant tumors, diabetes, and severe infections including sepsis is increasing, and patients with such disorders often find themselves in the ICU.Main bodyAge-related diseases are closely related to age-induced immune dysfunction, by which reductions in the efficiency and specificity of the immune system are collectively termed immunosenescence. The most noticeable is a decline in the antigen-specific acquired immune response. The exhaustion of T cells in elderly sepsis is related to an increase in nosocomial infections after septicemia, and even death over subacute periods. Another characteristic is that senescent cells that accumulate in body tissues over time cause chronic inflammation through the secretion of proinflammatory cytokines, termed senescence-associated secretory phenotype. Chronic inflammation associated with aging has been called inflammaging, and similar age-related diseases are becoming an urgent social problem.ConclusionIn neuro ICUs, several neuro-related diseases including stroke and sepsis-associated encephalopathy are related to immunosenescence and neuroinflammation in the elderly. Several advanced countries with superaged societies face the new challenge of improving the long-term prognosis of neurocritical patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Immunosenescence in neurocritical care
    Shigeaki Inoue
    Masafumi Saito
    Joji Kotani
    Journal of Intensive Care, 6
  • [2] Neurocritical Care
    Rabinstein, Alejandro A.
    NEUROLOGICAL RESEARCH, 2013, 35 (02) : 101 - 102
  • [3] Neurocritical care
    Suarez, JI
    JOURNAL OF NEUROSURGERY, 2006, 104 (05) : 711 - 712
  • [4] Neurocritical Care
    Maan, Muhammad Aasam Masoom
    ANAESTHESIA PAIN & INTENSIVE CARE, 2019, 23 (02) : 241 - 241
  • [5] Neurocritical Care Resource Utilization in Pandemics: A Statement by the Neurocritical Care Society
    Asma M. Moheet
    Angela H. Shapshak
    Megan A. Brissie
    Yasser B. Abulhasan
    Gretchen M. Brophy
    Jennifer Frontera
    Wiley R. Hall
    Sayona John
    Atul A. Kalanuria
    Abhay Kumar
    Abhijit V. Lele
    Shraddha Mainali
    Casey C. May
    Stephan A. Mayer
    Victoria McCredie
    Gisele S. Silva
    Jeffrey M. Singh
    Alexis Steinberg
    Gene Sung
    Eljim P. Tesoro
    Aleksandra Yakhkind
    Neurocritical Care, 2020, 33 : 13 - 19
  • [6] Neurocritical Care Resource Utilization in Pandemics: A Statement by the Neurocritical Care Society
    Moheet, Asma M.
    Shapshak, Angela H.
    Brissie, Megan A.
    Abulhasan, Yasser B.
    Brophy, Gretchen M.
    Frontera, Jennifer
    Hall, Wiley R.
    John, Sayona
    Kalanuria, Atul A.
    Kumar, Abhay
    Lele, Abhijit V.
    Mainali, Shraddha
    May, Casey C.
    Mayer, Stephan A.
    McCredie, Victoria
    Silva, Gisele S.
    Singh, Jeffrey M.
    Steinberg, Alexis
    Sung, Gene
    Tesoro, Eljim P.
    Yakhkind, Aleksandra
    NEUROCRITICAL CARE, 2020, 33 (01) : 13 - 19
  • [7] Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society
    Katja E. Wartenberg
    David Y. Hwang
    Karl Georg Haeusler
    Susanne Muehlschlegel
    Oliver W. Sakowitz
    Dominik Madžar
    Hajo M. Hamer
    Alejandro A. Rabinstein
    David M. Greer
    J. Claude Hemphill
    Juergen Meixensberger
    Panayiotis N. Varelas
    Neurocritical Care, 2019, 31 : 231 - 244
  • [8] Neurocritical Care for Neonates
    Hannah C. Glass
    Sonia L. Bonifacio
    Susan Peloquin
    Thomas Shimotake
    Sally Sehring
    Yao Sun
    Joseph Sullivan
    Elizabeth Rogers
    A. James Barkovich
    David Rowitch
    Donna M. Ferriero
    Neurocritical Care, 2010, 12 : 421 - 429
  • [9] Biomarkers in Neurocritical Care
    W. Taylor Kimberly
    Neurotherapeutics, 2012, 9 : 17 - 23
  • [10] Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society
    Wartenberg, Katja E.
    Hwang, David Y.
    Haeusler, Karl Georg
    Muehlschlegel, Susanne
    Sakowitz, Oliver W.
    Madzar, Dominik
    Hamer, Hajo M.
    Rabinstein, Alejandro A.
    Greer, David M.
    Hemphill, J. Claude, III
    Meixensberger, Juergen
    Varelas, Panayiotis N.
    NEUROCRITICAL CARE, 2019, 31 (02) : 231 - 244